PharmGKB summary: cyclosporine and tacrolimus pathways
- PMID: 23922006
- PMCID: PMC4119065
- DOI: 10.1097/FPC.0b013e328364db84
PharmGKB summary: cyclosporine and tacrolimus pathways
Conflict of interest statement
There are no conflicts of interest.
Figures


References
-
- Kapturczak MH, Meier-Kriesche HU, Kaplan B. Pharmacology of calcineurin antagonists. Transplant Proc. 2004;36:25S–32S. - PubMed
-
- Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR) OPTN/SRTR 2010 Annual Data Report. Vol. 2012 Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2011.
-
- Campbell S, McDonald S, Webster A, Excell L, Livingston B. Australia & New Zealand Dialysis and Transplant Registry: The 32nd Annual Report. 2009. Report - Data to 2008. Transplantation. 2009;Chapter 8
-
- Kapp A, Allen BR, Reitamo S. Atopic dermatitis management with tacrolimus ointment (Protopic) J Dermatolog Treat. 2003;14:5–16. - PubMed
-
- Lee SS, Tan AW, Giam YC. Cyclosporin in the treatment of severe atopic dermatitis: a retrospective study. Ann Acad Med Singapore. 2004;33:311–313. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous